1. MARKETS
  2. SECTOR : HEALTHCARE & MEDICAL EQUIPMENT SUPPLIERS
  3. INDUSTRY : MEDICAL SPECIALTIES
  4. HEART TEST LABORATORIES INC
Heart Test Laboratories Inc XNAS: HSCS
Download real time
3.92 -0.24 (-5.77%)
39.41% Fall from 52W High
31,184
XNAS Volume

XNAS 18 Jul, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Alert

Share


Insider Trading disclosures for Heart Test Laboratories Inc

The latest disclosure was made by Brian Szymczak in Heart Test Laboratories Inc where a trade of 25,000 Stock Option (Right to Buy) done was reported to US exchanges on July 9, 2025.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Brian Szymczak Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Jul 2025 25,000 25,000 - - Stock Option (Right to Buy)
Bruce Bent Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Jul 2025 25,000 25,000 - - Stock Option (Right to Buy)
Danielle Watson See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Jul 2025 25,000 25,000 - - Stock Option (Right to Buy)
Andrew Simpson Director, See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Jul 2025 68,750 68,750 - - Restricted Stock Units
Andrew Simpson Director, See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Jul 2025 275,000 275,000 - - Stock Option (Right to Buy)
David R. Wells Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Jul 2025 25,000 25,000 - - Stock Option (Right to Buy)
Mark T. Hilz Director, See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Jul 2025 225,000 225,000 - - Stock Option (Right to Buy)
Mark T. Hilz Director, See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Jul 2025 56,250 56,250 - - Restricted Stock Units
Danielle Watson See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Jan 2025 9,000 9,000 - - Employee Stock Option (Right to Buy)
Bruce Bent Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Jan 2025 6,000 6,000 - - Employee Stock Option (Right to Buy)
Brian Szymczak Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Jan 2025 6,000 6,000 - - Employee Stock Option (Right to Buy)
Andrew Simpson Director, See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Jan 2025 45,000 45,000 - - Employee Stock Option (Right to Buy)
David R. Wells Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Jan 2025 6,000 6,000 - - Employee Stock Option (Right to Buy)
Mark T. Hilz Director, See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Jan 2025 45,000 45,000 - - Employee Stock Option (Right to Buy)
Andrew Simpson Director, See Remarks Other type of transaction at price $ 0.00 per share. 12 Aug 2024 17 7,629 - - Common Stock, $0.001 par value
Mark T. Hilz Director, See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Mar 2023 300,000 300,000 - - Employee Stock Option (Right to Buy)
Brian Szymczak Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Mar 2023 50,000 50,000 - - Director Stock Option (Right to Buy)
Bruce Bent Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Mar 2023 50,000 50,000 - - Director Stock Option (Right to Buy)
Danielle Watson See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Mar 2023 75,000 75,000 - - Employee Stock Option (Right to Buy)
Andrew Simpson Director, See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Mar 2023 300,000 300,000 - - Employee Stock Option (Right to Buy)
David R. Wells Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Mar 2023 50,000 50,000 - - Director Stock Option (Right to Buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures
Screeners based on Insider Trading and SAST parameters